Inflammaging – Chronic Inflammation and Aging

What Is Inflammaging?

Inflammaging is a portmanteau of the words inflammation and aging. It describes a state of chronic, low-grade, systemic inflammation that progresses with advancing age, without an obvious external trigger such as infection or injury. Unlike acute inflammation — which is a normal and protective immune response — inflammaging is persistent and subclinical. It is now recognized as a central biological hallmark of aging and a key driver of numerous age-related diseases.

Causes and Mechanisms

The development of inflammaging is multifactorial. Several biological and lifestyle-related mechanisms are thought to contribute:

• Cellular Senescence: Aged cells that are no longer able to divide secrete a range of pro-inflammatory molecules, a phenomenon known as the SASP (Senescence-Associated Secretory Phenotype).
• Accumulation of Cellular Damage: The build-up of damaged DNA, misfolded proteins, and dysfunctional mitochondria chronically activates the immune system.
• Gut Dysbiosis: Age-related changes in the gut microbiome can impair the intestinal barrier, allowing bacterial endotoxins to enter the bloodstream and trigger inflammatory responses.
• Immunosenescence: The age-related decline in immune function means that inflammatory responses are less efficiently resolved and regulated.
• Oxidative Stress: Increased production of reactive oxygen species (free radicals) promotes inflammation at the cellular level.
• Lifestyle Factors: Obesity, physical inactivity, unhealthy diet, smoking, and chronic psychological stress can accelerate and worsen inflammaging.

Key Inflammatory Mediators

Inflammaging is characterized by persistently elevated levels of certain pro-inflammatory molecules in the blood. The most commonly measured biomarkers include:

• Interleukin-6 (IL-6)
• Tumor Necrosis Factor-alpha (TNF-alpha)
• Interleukin-1 beta (IL-1beta)
• C-Reactive Protein (CRP)
• Nuclear Factor kappa B (NF-kB) — a key transcription factor that activates inflammatory gene expression

These molecules are frequently found at elevated concentrations in the blood of older individuals and are considered molecular signatures of the inflammaging process.

Associated Diseases

Inflammaging has been linked to a broad spectrum of chronic, age-associated conditions, including:

• Cardiovascular diseases (e.g., atherosclerosis, myocardial infarction)
• Type 2 diabetes mellitus
• Neurodegenerative diseases (e.g., Alzheimer disease, Parkinson disease)
• Cancer
• Sarcopenia (age-related loss of muscle mass and strength)
• Osteoporosis
• Chronic kidney disease
• Depression and cognitive decline

Diagnosis

Inflammaging is not a formally diagnosed clinical condition, but rather a biological concept. It can be assessed through the measurement of inflammatory markers in the blood. Commonly used laboratory parameters include:

• CRP (C-reactive protein), especially high-sensitivity CRP (hs-CRP)
• Interleukin-6 (IL-6)
• TNF-alpha
• Complete blood count with differential

A comprehensive clinical evaluation, combined with imaging studies where appropriate, can help identify organ damage associated with chronic low-grade inflammation.

Treatment and Prevention

Because inflammaging is a complex, multifactorial process, there is no single treatment. Several approaches are considered promising:

Lifestyle Interventions

• Mediterranean diet: Rich in antioxidants, omega-3 fatty acids, and dietary fiber — shown to have anti-inflammatory effects in multiple studies.
• Regular physical activity: Both aerobic exercise and strength training have been shown to reduce levels of inflammatory markers.
• Caloric restriction and intermittent fasting: Associated with improved inflammatory profiles and extended healthspan in research settings.
• Adequate sleep: Chronic sleep deprivation is a recognized driver of systemic inflammation.
• Stress reduction: Mindfulness practices, meditation, and yoga have shown positive effects on inflammatory biomarkers.

Pharmacological and Experimental Approaches

• Senolytics: Compounds designed to selectively eliminate senescent cells (e.g., dasatinib, quercetin) — currently under clinical investigation.
• Metformin: The widely used antidiabetic drug is being studied for its potential anti-inflammatory and anti-aging effects.
• Rapamycin (mTOR inhibitor): Demonstrates lifespan-extending effects in animal models by modulating inflammatory pathways.
• Omega-3 fatty acids and polyphenols: Discussed as dietary supplements, though the clinical evidence remains inconsistent.

Relevance to Modern Medicine

The concept of inflammaging has gained considerable attention in gerontology and preventive medicine. It provides a unifying biological framework to explain why multiple chronic diseases so often co-occur in older adults — a phenomenon known as multimorbidity. As research advances, inflammaging is increasingly viewed not just as a passive consequence of aging, but as an active and potentially modifiable target for extending healthy lifespan.

References

1. Franceschi C., Bonafe M., Valensin S. et al. - Inflamm-aging. An evolutionary perspective on immunosenescence. Annals of the New York Academy of Sciences, 2000. DOI: 10.1111/j.1749-6632.2000.tb06651.x
2. Lopez-Otin C., Blasco M.A., Partridge L. et al. - The Hallmarks of Aging. Cell, 2013. DOI: 10.1016/j.cell.2013.05.039
3. World Health Organization (WHO) - Ageing and health. Fact sheet. Available at: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health